212 related articles for article (PubMed ID: 38732081)
1. Antiplatelet Effects of Flavonoid Aglycones Are Mediated by Activation of Cyclic Nucleotide-Dependent Protein Kinases.
Balykina A; Naida L; Kirkgöz K; Nikolaev VO; Fock E; Belyakov M; Whaley A; Whaley A; Shpakova V; Rukoyatkina N; Gambaryan S
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732081
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets.
Navarro-Núñez L; Rivera J; Guerrero JA; Martínez C; Vicente V; Lozano ML
Br J Pharmacol; 2009 Nov; 158(6):1548-56. PubMed ID: 19814731
[TBL] [Abstract][Full Text] [Related]
3. In vitro antiplatelet activity of flavonoids from Leuzea carthamoides.
Koleckar V; Brojerova E; Rehakova Z; Kubikova K; Cervenka F; Kuca K; Jun D; Hronek M; Opletalova V; Opletal L
Drug Chem Toxicol; 2008; 31(1):27-35. PubMed ID: 18161506
[TBL] [Abstract][Full Text] [Related]
4. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids.
Wright B; Moraes LA; Kemp CF; Mullen W; Crozier A; Lovegrove JA; Gibbins JM
Br J Pharmacol; 2010 Mar; 159(6):1312-25. PubMed ID: 20148891
[TBL] [Abstract][Full Text] [Related]
5. The activity comparison of six dietary flavonoids identifies that luteolin inhibits 3T3-L1 adipocyte differentiation through reducing ROS generation.
Zhao L; Zheng M; Cai H; Chen J; Lin Y; Wang F; Wang L; Zhang X; Liu J
J Nutr Biochem; 2023 Feb; 112():109208. PubMed ID: 36370929
[TBL] [Abstract][Full Text] [Related]
6. ML355 Modulates Platelet Activation and Prevents ABT-737 Induced Apoptosis in Platelets.
Shpakova V; Rukoyatkina N; Al Arawe N; Prilepskaya A; Kharazova A; Sharina I; Gambaryan S; Martin E
J Pharmacol Exp Ther; 2022 May; 381(2):164-175. PubMed ID: 35197320
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of thrombin-induced signaling by resveratrol and quercetin: effects on adenosine nucleotide metabolism in endothelial cells and platelet-neutrophil interactions.
Kaneider NC; Mosheimer B; Reinisch N; Patsch JR; Wiedermann CJ
Thromb Res; 2004; 114(3):185-94. PubMed ID: 15342215
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of aggregation and secretion of human platelets by quercetin and other flavonoids: structure-activity relationships.
Beretz A; Cazenave JP; Anton R
Agents Actions; 1982 Jul; 12(3):382-7. PubMed ID: 6182778
[TBL] [Abstract][Full Text] [Related]
9. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities.
Nagakura N; Saeki T; Harada K; Yoshitake S; Kobayashi S; Yamanaka T; Saito I
Biol Pharm Bull; 1996 Jun; 19(6):828-33. PubMed ID: 8799481
[TBL] [Abstract][Full Text] [Related]
11. DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase.
Ye J; Zhai L; Zhang S; Zhang Y; Chen L; Hu L; Zhang S; Ding Z
Platelets; 2015; 26(8):736-44. PubMed ID: 25734213
[TBL] [Abstract][Full Text] [Related]
12. Flavonoid inhibition of platelet procoagulant activity and phosphoinositide synthesis.
Bucki R; Pastore JJ; Giraud F; Sulpice JC; Janmey PA
J Thromb Haemost; 2003 Aug; 1(8):1820-8. PubMed ID: 12911599
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of platelet signal transduction as anti-aggregatory drugs.
Geiger J
Expert Opin Investig Drugs; 2001 May; 10(5):865-90. PubMed ID: 11322863
[TBL] [Abstract][Full Text] [Related]
14. Flavonoids inhibit tumor necrosis factor-alpha-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-kappaB: structure-activity relationships.
Chen CC; Chow MP; Huang WC; Lin YC; Chang YJ
Mol Pharmacol; 2004 Sep; 66(3):683-93. PubMed ID: 15322261
[TBL] [Abstract][Full Text] [Related]
15. In vitro antiplatelet activity of extract and its fractions of Paulownia Clone in Vitro 112 leaves.
Adach W; Żuchowski J; Moniuszko-Szajwaj B; Szumacher-Strabel M; Stochmal A; Olas B; Cieslak A
Biomed Pharmacother; 2021 May; 137():111301. PubMed ID: 33561640
[TBL] [Abstract][Full Text] [Related]
16. Effects of the vegetable polyphenols epigallocatechin-3-gallate, luteolin, apigenin, myricetin, quercetin, and cyanidin in primary cultures of human retinal pigment epithelial cells.
Chen R; Hollborn M; Grosche A; Reichenbach A; Wiedemann P; Bringmann A; Kohen L
Mol Vis; 2014; 20():242-58. PubMed ID: 24623967
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory mechanisms of CME-1, a novel polysaccharide from the mycelia of Cordyceps sinensis, in platelet activation.
Chang Y; Hsu WH; Lu WJ; Jayakumar T; Liao JC; Lin MJ; Wang SH; Geraldine P; Lin KH; Sheu JR
Curr Pharm Biotechnol; 2015; 16(5):451-61. PubMed ID: 25751172
[TBL] [Abstract][Full Text] [Related]
18. Novel roles of cAMP/cGMP-dependent signaling in platelets.
Smolenski A
J Thromb Haemost; 2012 Feb; 10(2):167-76. PubMed ID: 22136590
[TBL] [Abstract][Full Text] [Related]
19. Synthetic analogues of flavonoids with improved activity against platelet activation and aggregation as novel prototypes of food supplements.
Del Turco S; Sartini S; Cigni G; Sentieri C; Sbrana S; Battaglia D; Papa A; Da Settimo F; La Motta C; Basta G
Food Chem; 2015 May; 175():494-9. PubMed ID: 25577111
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase.
Dell'Agli M; Maschi O; Galli GV; Fagnani R; Dal Cero E; Caruso D; Bosisio E
Br J Nutr; 2008 May; 99(5):945-51. PubMed ID: 17927845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
